U of S Part of Canadian Team that Finds Popular Antidepressants May Affect Fetus

Posted April 06, 2006


The following news release was issued today by the Government of Canada.

U of S Part of Canadian Team that Finds Popular Antidepressants May
Affect Fetus

A Canadian research team led by the Ottawa Health Research Institute, the
University of Ottawa, and The Ottawa Hospital has found an increased risk of
premature delivery, low birth weight, fetal death, and infant seizures among
pregnant women who used a popular class of antidepressants during pregnancy.


The study, which also involved the University of Montreal and the University
of Saskatchewan, is published in the April issue of the American Journal of
Obstetrics and Gynecology.  U of S researcher Dr. Olufemi
Olatunbosun, chair of the department of obstetrics, gynecology and
reproductive sciences, is a co-author on the study. The data for
the study was obtained from the Saskatchewan Health Database, which is
unique in North America and which enables researchers to track prescription
drug use over patient lifetimes.

For more information, refer to the official news release:
http://www.ohri.ca/newsroom/newsstory.asp?ID=27


--------